Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Feb 1, 2022
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
General Notices
- Notice of Technical Assistance Webinar for RFA-AR-22-009, HEAL Initiative: Restoring Joint Health and Function to Reduce Pain Consortium (RE-JOIN)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute of Dental and Craniofacial Research
National Institute of Neurological Disorders and Stroke
- Notice of Participation of the National Institute of Dental and Craniofacial Research (NIDCR) in RFA-MD-22-004 Innovations for Healthy LivingImproving Minority Health and Eliminating Health Disparities (R43/R44- Clinical Trial Optional)
National Institute of Dental and Craniofacial Research
- NIDDK Encourages Research on Sex/Gender Differences, Sexual and Gender Minority-Related Research and Race/Ethnic Diversity
National Institute of Diabetes and Digestive and Kidney Diseases
- RESCINDED - Request for Information (RFI) on Advancing Research in Fundamental Neuroscience
National Institute of Neurological Disorders and Stroke
- Request for Information (RFI) on Advancing Research in Fundamental Neuroscience
National Institute of Neurological Disorders and Stroke
- Request for Public Comments on DRAFT Supplemental Information to the NIH Policy for Data Management and Sharing: Responsible Management and Sharing of American Indian/ Alaska Native Participant Data
Office of the Director, NIH
Notice of Changes to Funding Opportunities
- Notice of NIAAA's Participation in RFA-DA-22-047, "HEAL Initiative: Understanding Polysubstance Use and Improving Service Delivery to Address Polysubstance Use (R01 Clinical Trial Optional)"
National Institute on Alcohol Abuse and Alcoholism
- Notice of NIAAA's Participation in RFA-DA-22-048, "HEAL Initiative: Pilot & Feasibility Trials to Improve Prevention and Treatment Service Delivery for Polysubstance Use (R34 Clinical Trial Optional)"
National Institute on Alcohol Abuse and Alcoholism
- Notice of Correction to Award Project Period Information for PAS-19-316, "Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
National Institute on Aging
National Institute of Neurological Disorders and Stroke
- Notice of Correction to Award Project Period Information for PAS-19-317, "Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
National Institute on Aging
National Institute of Neurological Disorders and Stroke
- NEI Notice of Participation in PAR-20-310, "Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)"
National Eye Institute
- NEI Notice of Participation in PAR-21-081, "Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional)"
National Eye Institute
- NEI Notice of Participation in PAR-22-072, "Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed)"
National Eye Institute
- Notice of Change to Application Types Allowed for RFA-MH-22-120, "Pilot Practice-based Research for Primary Care Suicide Prevention (R34 Clinical Trial Optional)"
National Institute of Mental Health
- Notice to Extend the Expiration Date for PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)"
National Institutes of Health
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional)
National Cancer Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
National Cancer Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
National Cancer Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke
Notices of Special Interest
- Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Drug Abuse
National Institute of Mental Health
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research
- Notice of Special Interest (NOSI): Discovery of the Genetic Basis of Conditions Associated with Down Syndrome for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project (X01)
Office of the Director, NIH
National Heart, Lung, and Blood Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
- Notice of Special Interest (NOSI): Support for existing data repositories to align with FAIR and TRUST principles and evaluate usage, utility, and impact
Office of the Director, NIH
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Eye Institute
National Human Genome Research Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Library of Medicine
Funding Opportunities
- Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
National Institutes of Health
National Center for Complementary and Integrative Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of Neurological Disorders and Stroke
National Library of Medicine
- Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
- Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
- Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed)
- Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)
- Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed)
National Heart, Lung, and Blood Institute
- BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
- NIMH Instrumentation Program (S10 Clinical Trial Not Allowed)
National Institute of Mental Health
- Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional)
National Institute of Nursing Research
National Institute on Drug Abuse
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
- Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Required)
National Institute of Nursing Research
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Minority Health and Health Disparities
Office of Research on Women's Health
- Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R21 Clinical Trial Optional)
National Institute of Nursing Research
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Research on Women's Health
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu or Lynn Hudachek at lynn-hudachek@uiowa.edu.